What Is a Mosaic Embryo?
A mosaic embryo is a blastocyst that contains two or more genetically distinct cell lines within the same embryo, as detected by advanced genetic screening methods such as preimplantation genetic testing for aneuploidy (PGT-A). In the context of fertility and IVF, mosaicism means that some cells in the embryo have the normal (euploid) number of chromosomes, while others have structural or numerical chromosomal abnormalities (aneuploidy).
Mosaic embryos occupy a distinct category compared to fully euploid (chromosomally normal) and fully aneuploid embryos (chromosomally abnormal). With the increased use of PGT-A in IVF, mosaic results are being encountered more frequently, raising important questions about their viability, the risks to future offspring, and their role in assisted reproduction.
Key Point: Mosaicism detected by PGT-A may not always reflect the chromosomal makeup of the entire embryo or resulting child, and recent research shows that some mosaic embryos can result in healthy live births.
Key Takeaways
- Mosaic embryos have a mix of normal and abnormal cells within the same blastocyst, as identified by advanced genetic testing.
- PGT-A can detect mosaicism, usually through next-generation sequencing (NGS), differentiating between low-level and high-level mosaicism.
- Not all mosaic embryos are the same; classification depends on the percentage of abnormal cells (low-level vs. high-level).
- Mosaic embryos may be transferred if no fully euploid embryos are available, potentially leading to healthy live births.
- Embryo mosaicism explains some cases of embryo arrest and variable IVF outcomes.
- Clinical guidelines for mosaic embryo reporting and transfer are evolving based on new evidence (e.g., PGDIS guidelines).
- Live birth rates from mosaic embryo transfers are lower than from euploid embryos but are not negligible.
- Mosaic results can be segmental (partial chromosome changes) or whole chromosome mosaic.
- Mosaic embryo outcomes are highly individualized; careful counseling and consent are vital before transfer.
- Long-term outcomes for children born from mosaic embryo transfer are generally reassuring, but data are limited.
Table of Contents
- What Is a Mosaic Embryo?
- How Is Mosaicism Detected in Embryos?
- Types of Mosaicism: Low-Level, High-Level, Segmental, and Whole Chromosome
- Why Do Mosaic Embryos Matter in Fertility and IVF?
- Outcomes After Mosaic Embryo Transfer
- Clinical Guidelines: When to Transfer Mosaic Embryos
- Risks, Misconceptions, and Counseling Around Mosaic Embryos
- Quick Facts Table: Mosaic Embryo
- Comparing Mosaic, Euploid, and Aneuploid Embryos
- FAQ: Frequently Asked Questions About Mosaic Embryos
- References and Further Reading
- Disclaimer
How Is Mosaicism Detected in Embryos?
Mosaicism in embryos is most commonly identified during IVF cycles that use preimplantation genetic testing for aneuploidy (PGT-A). This process involves taking a biopsy of several cells from the trophectoderm (the part of the blastocyst that will form the placenta) and analyzing their chromosomal makeup using advanced methods like next-generation sequencing (NGS) or array comparative genomic hybridization (aCGH).
Key aspects of mosaicism detection:
- Biopsy stage: Mosaicism is most often detected at the blastocyst stage (day 5-7), from trophectoderm biopsy.
- Testing method: NGS is more sensitive than previous methods and allows quantification of the proportion of abnormal cells, hence the improved detection of mosaicism.
- Reporting thresholds: Whether an embryo is reported as low-level or high-level mosaic depends on the proportion of abnormal cells in the sample (see next section).
Did you know? The detection of mosaic embryos has increased significantly with the adoption of NGS-based PGT-A, bringing new insights but also uncertainties to IVF decision-making.
PGT-A does not biopsy cells from the inner cell mass (which becomes the fetus), so the true level of mosaicism in the future baby may differ from that seen in the trophectoderm sample.
Types of Mosaicism: Low-Level, High-Level, Segmental, and Whole Chromosome
Mosaic embryos are classified by the type and extent of chromosomal abnormality detected:
- Low-level mosaicism: Usually defined as aneuploidy in 20–40% of cells analyzed.
- High-level mosaicism: Defined as aneuploidy in >40–80% of cells analyzed.
- Segmental mosaic: Only part of a chromosome (segment) is abnormal, rather than the whole chromosome.
- Whole chromosome mosaic: An entire chromosome is gained or lost in a subset of cells.
Classification schemes (percentages):
| Type of Mosaicism | Percentage of Abnormal Cells | Notes |
|---|---|---|
| Euploid | 0% (normal) | All cells are chromosomally normal |
| Low-level mosaic | 20–40% | 20–40% abnormal, rest normal |
| High-level mosaic | >40–80% | 40–80% abnormal, rest normal |
| Aneuploid | >80% | Majority of cells abnormal |
Thresholds vary slightly among labs, so results should always be interpreted in the context of the reporting laboratory's criteria.
Examples:
- A blastocyst tested with 30% of cells showing trisomy 16 would be classified as low-level mosaic for trisomy 16.
- A result where 60% of cells have monosomy X (missing an X chromosome) is considered high-level mosaic for monosomy X.
Key Point: Not all mosaic embryos have the same level of risk or likelihood of successful pregnancy and healthy baby—both the percentage and type of mosaicism matter.
Why Do Mosaic Embryos Matter in Fertility and IVF?
How Mosaicism Affects Reproductive Outcomes
- Embryo selection: Many IVF cycles using PGT-A result in no euploid embryos available for transfer. In these scenarios, mosaic embryos may be considered for transfer, offering additional chances for pregnancy.
- Live birth potential: Recent studies show that some mosaic embryos can result in healthy pregnancies and live births, challenging the notion that only euploid embryos are worth transferring (Noyes et al, 2019, Greco et al, 2015).
- Risk of miscarriage and abnormal outcomes: The risk of miscarriage and chromosomal problems in offspring appears to be higher for mosaic embryo transfers than for euploid, but much lower than with fully aneuploid embryos.
- Ethical and practical implications: Deciding whether to transfer a mosaic embryo involves complex discussions about risks, uncertainties, and personal values.
Who Encounters Mosaic Embryos?
- People who have undergone PGT-A testing: Particularly those with a history of recurrent pregnancy loss, advanced age, or previous IVF failure.
- Intended parents facing no euploid embryos: Mosaic embryos provide an option when no chromosomally normal embryos are available.
Influence on Success Rates and Decision-Making
- Clinic policy: Not all fertility clinics offer mosaic embryo transfers. Policies depend on local regulations, lab protocols, and emerging data.
- Decision-making: Intended parents must be carefully counseled about the specific findings, risks, and expected outcomes associated with transferring a mosaic embryo.
Outcomes After Mosaic Embryo Transfer
What Does the Evidence Show?
- Implantation rates: Lower than with euploid embryos, but not negligible. Recent studies report implantation rates for low-level mosaic embryos ranging from 30–40%, compared to ~50% for euploid (Munne et al, 2017).
- Live birth rates: For low-level mosaic embryos, live birth rates after transfer are approximately 20–40%, only modestly reduced versus euploid embryos (Greco et al, 2015; Victor et al, 2019).
- Miscarriage risk: Increased compared to euploid embryos; the risk of miscarriage after mosaic embryo transfer depends on the type and level of mosaicism.
- Adverse outcomes: To date, most reported live births from transferred mosaic embryos have resulted in chromosomally normal or only mildly affected children (Spinella et al, 2018).
- Long-term health: Published data remain sparse, but current evidence is reassuring for most transferred mosaic embryos resulting in healthy children.
Table: Approximate Success Rates after Transfer
(based on available studies; actual rates may vary by clinic and patient factors)
| Embryo Category | Implantation Rate | Live Birth Rate | Miscarriage Rate |
|---|---|---|---|
| Euploid | 50–60% | 45–55% | 10–15% |
| Low-level Mosaic | 30–40% | 20–40% | 20–30% |
| High-level Mosaic | ~15–25% | 10–20% | 30–40% |
| Aneuploid | <5% | <1% | >40% |
Numbers are illustrative and subject to change as new data emerge.
Clinical Guidelines: When to Transfer Mosaic Embryos
Professional organizations such as the Preimplantation Genetic Diagnosis International Society (PGDIS) and the American Society for Reproductive Medicine (ASRM) address mosaic embryo transfer in their evolving guidelines.
Key points from current guidelines (as of 2024):
- Mosaic embryo transfer is considered when no euploid embryos are available for transfer or when patients decline further IVF cycles.
- Low-level mosaic embryos are generally preferred over high-level mosaics for transfer due to better outcomes and reduced risk.
- Counseling is required: Detailed counseling regarding uncertain risks and available data must be documented prior to transfer.
- Prenatal diagnosis is always recommended after a mosaic embryo transfer, typically via chorionic villus sampling (CVS) or amniocentesis.
Did you know? The reporting of mosaicism is optional in some labs and regulated in others; always ask your clinic how they report mosaic findings.
PGDIS Mosaic Embryo Recommendations
- Transfer prioritization: Euploid > low-level mosaic > high-level mosaic > aneuploid.
- Type of chromosomal abnormality: Mosaic embryos with low-level segmental aneuploidy may be less risky than those involving whole chromosome changes.
Risks, Misconceptions, and Counseling Around Mosaic Embryos
Common Concerns
-
"Will a transferred mosaic embryo lead to a baby with chromosomal disorders?"
- Most live births after mosaic embryo transfer are chromosomally normal, but there is a small risk depending on the chromosomes involved.
-
"Is the risk the same for all types of mosaicism?"
- No. Risks depend on the specific chromosome, degree of mosaicism, and whether the abnormality is segmental or whole chromosome.
Myths vs. Facts Table: Mosaic Embryo
| Myth | Fact |
|---|---|
| All mosaic embryos lead to abnormal pregnancies. | Most result in healthy pregnancies; risks depend on type and degree of mosaicism. |
| Mosaic embryos are always lower in quality. | Some mosaic embryos can self-correct and result in healthy babies. |
| Mosaic results reflect the baby exactly. | Mosaicism is tested in the trophectoderm; the inner cell mass may differ genetically. |
| Mosaic embryos should never be transferred. | Guidelines support transfer in specific situations, with careful counseling. |
| Transferring a mosaic embryo is dangerous. | Risks exist, but careful selection and monitoring reduce the chances of adverse outcomes. |
Key Point: Mosaic embryo counseling should be individualized, weighing risks, reproductive history, and family preferences.
Quick Facts Table: Mosaic Embryo
| Attribute | Description |
|---|---|
| Definition | Embryo with two or more genetically distinct cell lines (normal/abnormal karyotypes) |
| Diagnostic method | PGT-A (commonly with NGS technology) |
| Types | Low-level, high-level, segmental, whole chromosome |
| Relevance | IVF with embryo selection, especially when no euploid embryos are available |
| Transfer outcomes | Lower implantation/live birth rates than euploid, higher miscarriage risk |
| Potential children health | Most children reported chromosomally normal; rare risk of mosaicism or birth defects |
| Guidelines | PGDIS, ASRM: Prioritize euploid > mosaic > aneuploid; always counsel before transfer |
| Prenatal follow-up | Prenatal testing (CVS, amnio) recommended after mosaic embryo transfer |
| Insurance coverage | Varies by region and policy; often not specifically addressed for mosaic transfer |
Comparing Mosaic, Euploid, and Aneuploid Embryos
| Attribute | Euploid Embryo | Mosaic Embryo | Aneuploid Embryo |
|---|---|---|---|
| Chromosome status | All cells normal | Mix of normal and abnormal cells | All cells abnormal |
| Detected by PGT-A | Yes | Yes (PGT-A, especially via NGS) | Yes |
| IVF success rate | Highest | Intermediate—lower than euploid, higher than aneuploid | Lowest |
| Risk of issues | Lowest | Variable, depends on type and degree of mosaicism | Highest |
| Transfer guidance | First choice for transfer | Consider if no euploid; detailed counseling required | Not recommended for transfer |
FAQ: Frequently Asked Questions About Mosaic Embryos
What does "mosaic embryo" mean in IVF?
A mosaic embryo is a blastocyst with a mixture of normal (euploid) and abnormal (aneuploid) cells as detected by genetic testing. This situation arises when, during early development, some cells acquire chromosomal changes while others remain normal.
In IVF, this result means that the embryo is neither fully normal nor fully abnormal and brings up questions about reproductive potential, risks, and the advisability of proceeding with a transfer.
What is "mosaic PGT-A"?
Mosaic PGT-A refers to the detection of mosaicism during preimplantation genetic testing for aneuploidy. It occurs when the test identifies a mix of euploid and aneuploid cell lines within a single embryo.
PGT-A can quantify the proportion of abnormal cells, distinguishing between low-level and high-level mosaic embryos, which can inform embryo selection and counseling.
What is the difference between low-level and high-level mosaicism?
Low-level mosaicism usually means 20–40% of the sampled embryonic cells are abnormal, while high-level mosaicism means >40–80% of cells are abnormal. The risk of miscarriage or chromosomal problems increases with more abnormal cells.
Clinics may give greater priority to transferring low-level mosaic embryos, as they tend to have better outcomes and lower associated risks than high-level mosaics.
How is mosaicism detected in embryos during IVF?
Mosaicism is detected using PGT-A, most commonly with NGS technology. A few trophectoderm cells are biopsied from the blastocyst, and their chromosomal makeup is analyzed.
Next-generation sequencing enables quantification of the proportion of aneuploid cells present in the sample, allowing the embryo to be classified as euploid, low-level mosaic, high-level mosaic, or aneuploid.
Is it safe to transfer a mosaic embryo?
The safety of transferring a mosaic embryo depends on the level and type of mosaicism present but, in selected cases, can result in healthy pregnancies and live births. Comprehensive counseling is essential.
The available evidence shows that many transfers lead to healthy outcomes, though the risks of miscarriage, chromosomal, or developmental abnormalities are higher than with euploid embryos. Prenatal testing is strongly recommended following a mosaic embryo transfer.
What are segmental and whole chromosome mosaic embryos?
A segmental mosaic embryo has partial chromosome gains or losses (only a portion of a chromosome is affected), while a whole chromosome mosaic embryo involves one or more entire chromosomes gained or lost in some cells.
Segmental mosaicism may carry a lower risk of clinical problems, but the exact implications depend on which chromosome(s) are affected and whether the abnormality is present in the fetus or confined to the placenta.
What is the likelihood of a live birth from a mosaic embryo?
Current studies show live birth rates from transferred low-level mosaic embryos are roughly 20–40%. High-level mosaic embryos have success rates closer to 10–20%.
While these rates are lower than from euploid embryos, the possibility of a healthy live birth makes mosaic embryo transfer an important option for some would-be parents.
Are children born from mosaic embryos healthy?
Most children born after the transfer of mosaic embryos have normal chromosomes and development, according to published studies. However, there is a small risk of chromosomal abnormalities depending on the specific mosaicism.
Long-term data remain limited, and all pregnancies following mosaic embryo transfer warrant careful prenatal and pediatric follow-up.
Can mosaic embryos "self-correct" during development?
There is evidence that some mosaic embryos can "self-correct" by eliminating abnormal cells as development progresses, producing a healthy fetus. However, this cannot be guaranteed and depends on the type of mosaicism.
"Self-correction" is more likely with low-level mosaics and certain chromosomal abnormalities, making some mosaic embryo transfers reasonable when no euploid embryos are available.
Does mosaicism mean something is wrong with the parent’s genetics?
No, mosaicism in embryos is typically a random error occurring during early cell divisions after fertilization, not a reflection of inherited parental genetic problems.
The risk of mosaicism increases with factors like maternal age and may be more frequent in embryos from older eggs.
How common are mosaic embryos in IVF?
Estimates suggest that 15–20% of embryos biopsied in IVF and tested via NGS-PGT-A are reported as mosaic. The actual percentage can vary by patient age, clinic, and testing platform (Maxwell et al, 2016).
As detection technologies improve, the reported frequency of mosaicism is expected to increase.
Should mosaic embryos be transferred if no euploid embryos are available?
Current guidelines allow for the transfer of mosaic embryos—preferably low-level mosaic—as a reasonable option when no euploid embryos exist. Patients must be fully counseled about the risks and uncertainties.
Decisions should consider the nature of the chromosomal abnormality, level and type of mosaicism, embryo quality, and patient preferences or health conditions.
Is there a way to reduce the risk of embryo mosaicism in IVF?
There is currently no proven way to reliably reduce the risk of mosaicism in embryos. Age, especially advanced maternal age, is the most well-known risk factor. Attention to optimal ovarian stimulation, egg quality, and lab procedures may help, but evidence is limited.
Use of donor eggs from younger individuals may reduce embryo mosaicism rates for patients at higher maternal ages.
What prenatal follow-up is needed after a mosaic embryo transfer?
Prenatal diagnostic testing with amniocentesis or CVS is recommended following mosaic embryo transfer to confirm fetal chromosomal status.
Non-invasive prenatal testing (NIPT) may not reliably detect all chromosomal abnormalities after a mosaic embryo transfer.
Do insurance companies cover PGT-A and mosaic embryo transfer?
Coverage for PGT-A and mosaic embryo transfer is variable and depends on location, insurance plan, and clinic policy. Mosaic embryo transfer is often not specifically addressed by insurers.
Some plans may cover PGT-A if there are specific indications such as recurrent pregnancy loss or advanced maternal age.
What questions should I ask my fertility doctor about mosaic embryos?
You should ask about:
- The type and level of mosaicism
- Risks and benefits of transferring your specific mosaic embryo
- Alternatives if you do not wish to transfer a mosaic embryo
- The clinic’s experience and outcomes with mosaic embryo transfers
- Prenatal testing and follow-up recommendations
How are PGDIS and other professional organizations addressing mosaic embryos?
The PGDIS and ASRM have provided evolving recommendations for the interpretation and reporting of mosaic embryos, favoring euploid first, then low-level, then high-level mosaic embryos for transfer when necessary.
They emphasize the importance of individualized counseling, informed consent, and robust prenatal follow-up.
Are clinics required to report mosaic embryo findings?
Reporting practices vary by country and laboratory. In the United States and many other countries, labs using NGS-based PGT-A generally report mosaic results, but patients should check with their clinic or genetics provider about local practice.
Not all clinics offer the option to transfer mosaic embryos, so it is important to confirm policies when planning treatment.
References and Further Reading
- Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. https://pubmed.ncbi.nlm.nih.gov/26031820/
- Noyes N, et al. Mosaic embryo transfer: Data from the United States and Europe—impact and outcomes. https://pubmed.ncbi.nlm.nih.gov/31489676/
- Munne S, et al. Clinical outcomes after the transfer of mosaic embryos: A prospective multicenter study. https://pubmed.ncbi.nlm.nih.gov/28612574/
- Maxwell SM, et al. Prevalence and clinical relevance of chromosomal mosaicism in IVF embryos. https://pubmed.ncbi.nlm.nih.gov/27072590/
- Victor AR, et al. Viability of human blastocysts by degree of chromosomal mosaicism. https://pubmed.ncbi.nlm.nih.gov/30772484/
- Spinella F, et al. Preimplantation genetic testing for chromosomal abnormalities and embryo mosaicism. https://pubmed.ncbi.nlm.nih.gov/29457650/
- PGDIS. Position Statement on the Transfer of Mosaic Embryos. https://pgdis.org/position-statement-on-transfer-of-mosaic-embryos/
- American Society for Reproductive Medicine (ASRM): Practice Committee Guidance. https://www.asrm.org/
- Centers for Disease Control and Prevention (CDC): Assisted Reproductive Technology Report. https://www.cdc.gov/art/
- European Society of Human Reproduction and Embryology (ESHRE): Mosaic embryo guidance. https://www.eshre.eu/
Disclaimer
This article is for informational and educational purposes only and does not constitute medical or mental health advice. It is not a substitute for speaking with a qualified healthcare provider, licensed therapist, or other professional who can consider your individual situation.
